Althea Group Holdings Ltd (ASX: AGH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Althea Group Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $13.78 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 406.50 million
Earnings per share -0.085
Dividend per share N/A
Year To Date Return -12.82%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Althea Group Holdings Ltd (ASX: AGH)
    Latest News

    a woman
    Share Fallers

    Althea Group Holdings share price up 27% despite Aphria short seller attack

    The Althea Group Holdings Ltd (ASX:AGH) share price is up 27% this morning despite a short seller attack on major…

    Read more »

    a woman
    Share Gainers

    These small cap ASX shares are ending the week with strong gains

    The Althea Group Holdings Ltd (ASX:AGH) share price is one of three at the small end of the market ending…

    Read more »

    a woman
    Share Gainers

    Why this cannabis company's shares rocketed 39% higher today

    The Althea Group Holdings Ltd (ASX:AGH) share price has been a huge mover on the ASX on Friday. Here's why...

    Read more »

    AGH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Althea Group Holdings Ltd

    Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, andCorporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into geographic segments: Australia, the United Kingdom, Canada, Germany and Ireland. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

    AGH Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    02 Dec 2024 $0.03 $0.00 0.00% 191,552 $0.04 $0.04 $0.03
    29 Nov 2024 $0.04 $0.00 0.00% 824,049 $0.04 $0.04 $0.04
    28 Nov 2024 $0.04 $0.00 0.00% 141,654 $0.04 $0.04 $0.04
    27 Nov 2024 $0.04 $0.00 0.00% 63,306 $0.04 $0.04 $0.04
    26 Nov 2024 $0.04 $0.00 0.00% 869,514 $0.04 $0.04 $0.04
    25 Nov 2024 $0.04 $0.00 0.00% 1,002,352 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    01 Nov 2024 Vaughan Webber Buy 1,000,000 $44,485
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Alan Maclean Boyd Non-Executive Director Jun 2018
    Mr Boyd started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors. He is Chair of the Risk and Compliance Management Committee.
    Mr Vaughan Webber Non-Executive ChairmanNon-Executive Director Aug 2024
    Mr Webber is a company director and finance executive with over 20 years of experience, His career highlights include Non-Executive Director, HUB24 Ltd (ASX:HUB) (2012-2018), Independent Chairman, Wentworth Holdings Ltd (ASX:WWM) (2009-2013) ,Ltd (ASX:TOP) Independent Chairman, Solvar Ltd (ASX:SVR) (2014-2016), Non-Executive Director, Anchor Resources Ltd (ASX:AHR) (2011-2019). Mr Webber currently holds a number of Board roles including Chairman in the private sector.
    Mr Joshua Michael Fegan Chief Executive OfficerManaging Director Jun 2018
    Mr Fegan is the founder of Althea Group Holdings Limited and has experience in business building, sales and marketing. He has a range of business and strategy skills and has previously held a number of senior management roles at national value-based retailer, Strathfield Group.
    Penelope Dobson Non-Executive Director Nov 2018
    Ms Dobson is an experienced global healthcare executive. She has worked in the broad life-science space since her training as a pharmacist in New Zealand, including many years in the global pharmaceutical industry. She is a member of the Risk and Compliance Management Committee.
    Mr Adam John Gallagher Company Secretary Dec 2024
    -
    Mr Robert Meissner Chief Financial Officer Apr 2019
    -
    Robert Meissner Chief Financial Officer
    -
    Adam John Gallagher Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Adman Lanes Pty Ltd 60,000,000 14.76%
    Joshua Michael Fegan 57,444,030 14.13%
    UBS Nominees Pty Ltd 10,769,451 2.65%
    Citicorp Nominees Pty Limited 10,558,096 2.60%
    Mancann Pty Ltd 10,000,000 2.46%
    Hootch Pty Ltd 7,500,000 1.85%
    Hunt Prosperity Pty Ltd Investius PB Micro Cap A/C> 7,500,000 1.85%
    Hosanda Corporation Pty Limited 6,500,000 1.60%
    Mr Thomas Mark Nowak 5,000,000 1.23%
    HSBC Custody Nominees (Australia) Limited 4,807,529 1.18%
    Pither Investments Pty Ltd Pither Investments A/C> 4,800,000 1.18%
    Rizzo Super Pty Ltd Rizzo Super Fund A/C> 4,500,000 1.11%
    McLennan Trading Pty Ltd 4,100,000 1.01%
    Kevevans Pty Ltd 3,850,000 0.95%
    Vidog Capital Pty Ltd 3,770,834 0.93%
    Mr Orlando Alfredo Guerra Curvelo 3,500,000 0.86%
    Mrs Nola Kendall Fletcher 3,250,000 0.80%
    Nintieth Y Pty Ltd I K Cldwell & Co Staff A/C> 3,000,000 0.74%
    HSBC Custody Nominees (Australia) Limited A/C 2 2,952,629 0.73%
    Mr Hooi Giap Toh Yang and Toh Family A/C> 2,500,000 0.62%

    Profile

    since

    Note